NCT06911333 - AD1208 in Subjects With Any Progressive, Locally Advanced or Metastatic Solid Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 11, 2025

Primary Completion Date

June 30, 2029

Study Completion Date

February 20, 2030

Conditions

Solid Tumor, AdultTumor, SolidSolid TumorSolid Tumor, Unspecified, AdultSolid Tumor CancerSolid Tumors Refractory to Standard TherapySolid Tumor in Advanced Stage

Interventions

DRUG

AD1208

Up to 6 of cohorts will be applied sequentially in phase Ia part.

Trial Locations (3)

13620

RECRUITING

Seoul National University Bundang Hospital, Seongnam-si

03722

RECRUITING

Severance Hospital, Seoul

06351

RECRUITING

Samsung Medical Center, Seoul